233 related articles for article (PubMed ID: 35557589)
1. CCDC68 predicts poor prognosis in patients with colorectal cancer: a study based on TCGA data.
Zhang W; Xu TT; An ZT; Wei LF; Gu C; Li H; Tian YZ
J Gastrointest Oncol; 2022 Apr; 13(2):657-671. PubMed ID: 35557589
[TBL] [Abstract][Full Text] [Related]
2. MiR-3614-5p Is a Potential Novel Biomarker for Colorectal Cancer.
Han L; Sun Y; Lu C; Ma C; Shi J; Sun D
Front Genet; 2021; 12():666833. PubMed ID: 34127929
[TBL] [Abstract][Full Text] [Related]
3. LncRNA PCAT6 is a predictor of poor prognosis of colorectal cancer.
Han L; Li Z; Zhang P; Sheng M; Wang W; Sun Y; Sun D
J Gastrointest Oncol; 2024 Feb; 15(1):190-202. PubMed ID: 38482211
[TBL] [Abstract][Full Text] [Related]
4. Overexpression of NOP58 as a Prognostic Marker in Hepatocellular Carcinoma: A TCGA Data-Based Analysis.
Wang J; Huang R; Huang Y; Chen Y; Chen F
Adv Ther; 2021 Jun; 38(6):3342-3361. PubMed ID: 34014550
[TBL] [Abstract][Full Text] [Related]
5. LncRNA MIR4435-2HG predicts poor prognosis in patients with colorectal cancer.
Ouyang W; Ren L; Liu G; Chi X; Wei H
PeerJ; 2019; 7():e6683. PubMed ID: 30972258
[TBL] [Abstract][Full Text] [Related]
6. Prognostic value of LINC02560 in colorectal cancer correlates with tumor microenvironment immunity.
Luo C; Liu F; Su W; Long P; Liang J; Hou W; Jiang H; Long X; Su G
J Cancer; 2021; 12(24):7507-7517. PubMed ID: 35003370
[No Abstract] [Full Text] [Related]
7. LncRNA MSC-AS1 Is a Diagnostic Biomarker and Predicts Poor Prognosis in Patients With Gastric Cancer by Integrated Bioinformatics Analysis.
Yang W; Ge F; Lu S; Shan Z; Peng L; Chai J; Liu H; Li B; Zhang Z; Huang J; Hua Y; Zhang Y
Front Med (Lausanne); 2021; 8():795427. PubMed ID: 34926534
[TBL] [Abstract][Full Text] [Related]
8. Long non-coding RNA FOXP4-AS1 is a prognostic biomarker and associated with immune infiltrates in ovarian serous cystadenocarcinoma.
Liao C; Wang A; Ma Y; Liu H
Medicine (Baltimore); 2021 Oct; 100(40):e27473. PubMed ID: 34622876
[TBL] [Abstract][Full Text] [Related]
9. Correlation of autophagy-related genes for predicting clinical prognosis in colorectal cancer.
Liu L; Zhang J; Liu H; Shi M; Zhang J; Chen L; Huang L; Li B; Xu P
Biomark Med; 2021 Jun; 15(10):715-729. PubMed ID: 34169735
[No Abstract] [Full Text] [Related]
10. HTRA3 Is a Prognostic Biomarker and Associated With Immune Infiltrates in Gastric Cancer.
Ji C; Sun LS; Xing F; Niu N; Gao HL; Dai JW; Zhou N; Jiang BC
Front Oncol; 2020; 10():603480. PubMed ID: 33425760
[TBL] [Abstract][Full Text] [Related]
11. Ring finger protein 215 is a potential prognostic biomarker involved in immune infiltration and angiogenesis in colorectal cancer.
Wu JB; Li XJ; Liu H; Liu XP
Biomed Rep; 2023 Jul; 19(1):50. PubMed ID: 37383678
[TBL] [Abstract][Full Text] [Related]
12. Overexpression of LBX2 associated with tumor progression and poor prognosis in colorectal cancer.
Huang X; Yang Y; Yang C; Li H; Cheng H; Zheng Y
Oncol Lett; 2020 Jun; 19(6):3751-3760. PubMed ID: 32382328
[TBL] [Abstract][Full Text] [Related]
13. Increased expression of RUNX1 in clear cell renal cell carcinoma predicts poor prognosis.
Fu Y; Sun S; Man X; Kong C
PeerJ; 2019; 7():e7854. PubMed ID: 31592165
[TBL] [Abstract][Full Text] [Related]
14. NDUFA4L2 is a novel biomarker for colorectal cancer through bioinformatics analysis.
Lin Y; Xie H; Zhao W; Li Y; Zhang Z
Medicine (Baltimore); 2023 Nov; 102(44):e35893. PubMed ID: 37933010
[TBL] [Abstract][Full Text] [Related]
15. Abnormal expression of ABCD3 is an independent prognostic factor for colorectal cancer.
Zhang Y; Zhang Y; Wang J; Yang J; Yang G
Oncol Lett; 2020 May; 19(5):3567-3577. PubMed ID: 32269631
[TBL] [Abstract][Full Text] [Related]
16. Decreased expression of TFAP2B in endometrial cancer predicts poor prognosis: A study based on TCGA data.
Wu H; Zhang J
Gynecol Oncol; 2018 Jun; 149(3):592-597. PubMed ID: 29602546
[TBL] [Abstract][Full Text] [Related]
17. Coiled-Coil Domain-Containing 68 Downregulation Promotes Colorectal Cancer Cell Growth by Inhibiting ITCH-Mediated CDK4 Degradation.
Wang C; Li H; Wu L; Jiao X; Jin Z; Zhu Y; Fang Z; Zhang X; Huang H; Zhao L
Front Oncol; 2021; 11():668743. PubMed ID: 33968776
[TBL] [Abstract][Full Text] [Related]
18. Increased E2F2 predicts poor prognosis in patients with HCC based on TCGA data.
Zeng Z; Cao Z; Tang Y
BMC Cancer; 2020 Oct; 20(1):1037. PubMed ID: 33115417
[TBL] [Abstract][Full Text] [Related]
19. Decreased expression of TXNIP predicts poor prognosis in patients with clear cell renal cell carcinoma.
Gao Y; Qi JC; Li X; Sun JP; Ji H; Li QH
Oncol Lett; 2020 Jan; 19(1):763-770. PubMed ID: 31897192
[TBL] [Abstract][Full Text] [Related]
20. PCGF1 is a prognostic biomarker and correlates with tumor immunity in gliomas.
Xie J; Qiao L; Deng G; Liang N; Xing L; Zhang J
Ann Transl Med; 2022 Feb; 10(4):227. PubMed ID: 35280367
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
